EFFECTS OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK-421 IN HUMAN HYPERTENSION

被引：19

作者：

GAVRAS, H

BIOLLAZ, J

WAEBER, B

BRUNNER, HR

GAVRAS, I

DAVIES, RO

机构：

[1] BOSTON CITY HOSP, THORNDIKE MEM LAB, BOSTON, MA 02118 USA

[2] CHU LAUSANNE, LAUSANNE, SWITZERLAND

[3] MERCK SHARP & DOHME, West Point, PA 19486 USA

来源：

CLINICAL AND EXPERIMENTAL HYPERTENSION | 1982年 / 4卷 / 1-2期

关键词：

D O I：

10.3109/10641968209061593

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：303 / 314

页数：12

共 29 条

[1]

BIOLLAZ J, 1981, CLIN PHARM THER

[2] CONVERTING ENZYME-INHIBITION WITH AN ORALLY ACTIVE COMPOUND IN HYPERTENSIVE MAN [J].

BRAVO, EL ;

TARAZI, RC .

HYPERTENSION, 1979, 1 (01) :39-46

[3] EFFECT OF A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK 421 AND ITS LYSINE ANALOG ON THE COMPONENTS OF THE RENIN SYSTEM IN HEALTHY-SUBJECTS [J].

BRUNNER, DB ;

DESPONDS, G ;

BIOLLAZ, J ;

KELLER, I ;

FERBER, F ;

GAVRAS, H ;

BRUNNER, HR ;

SCHELLING, JL .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (05) :461-467

[4] ORAL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR IN LONG-TERM TREATMENT OF HYPERTENSIVE PATIENTS [J].

BRUNNER, HR ;

GAVRAS, H ;

WAEBER, B ;

KERSHAW, GR ;

TURINI, GA ;

VUKOVICH, RA ;

MCKINSTRY, DN ;

GAVRAS, I .

ANNALS OF INTERNAL MEDICINE, 1979, 90 (01) :19-23

[5]

CUSHMAN DW, 1969, FED PROC, V28, P799

[6] SPECTROPHOTOMETRIC ASSAY AND PROPERTIES OF ANGIOTENSIN-CONVERTING ENZYME OF RABBIT LUNG [J].

CUSHMAN, DW ;

CHEUNG, HS .

BIOCHEMICAL PHARMACOLOGY, 1971, 20 (07) :1637-+

[7] TREATMENT OF CHRONIC CONGESTIVE HEART-FAILURE WITH CAPTOPRIL, AN ORAL INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME [J].

DAVIS, R ;

RIBNER, HS ;

KEUNG, E ;

SONNENBLICK, EH ;

LEJEMTEL, TH .

NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (03) :117-121

[8] ESTIMATION OF ANGIOTENSIN II CONCENTRATION IN HUMAN PLASMA BY RADIOIMMUNOASSAY - SOME APPLICATIONS TO PHYSIOLOGICAL AND CLINICAL STATES [J].

DUSTERDIECK, G ;

MCELWEE, G .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1971, 2 (01) :32-+

[9] ANGIOTENSIN CONVERTING-ENZYME INHIBITOR TO IDENTIFY AND TREAT VASOCONSTRICTOR AND VOLUME FACTORS IN HYPERTENSIVE PATIENTS [J].

GAVRAS, H ;

BRUNNER, HR ;

LARAGH, JH ;

SEALEY, JE ;

GAVRAS, I ;

VUKOVICH, RA .

NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (16) :817-821

[10]

GAVRAS H, 1978, CIRC RES, V43, pI59

← 1 2 3 →